Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Weir

Showing results (361-370 of 380) with videos related to

Pageof 38
Sort By:
JAMA|January 9, 2019
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical TrialPeter J McCartney, Hany Eteiba, Annette M Maznyczka, et al.
The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
Kidney International|March 28, 2026
Genetic testing in kidney transplantation and living kidney donor risk assessmentClara Schott, Sydney Relouw, Monica Arnaldi, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Nature|October 23, 2009
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A Barbie, Pablo Tamayo, Jesse S Boehm, et al.
Genes|April 26, 2025
Genetic Testing in Adults over 50 Years with Chronic Kidney Disease: Diagnostic Yield and Clinical Implications in a Specialized Kidney Genetics ClinicClara Schott, Mohammad Alajmi, Mohammad Bukhari, et al.
Cell Systems|August 25, 2017
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular StatesJong Wook Kim, Omar O Abudayyeh, Huwate Yeerna, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Scientific Data|May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependenciesGlenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Neuron|February 13, 2018
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent ExcitabilityJohn M Dawes, Greg A Weir, Steven J Middleton, et al.
Pageof 38

Showing results (361-370 of 380) with videos related to

Sort By:
Pageof 38
JAMA|January 9, 2019
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical TrialPeter J McCartney, Hany Eteiba, Annette M Maznyczka, et al.
The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
Kidney International|March 28, 2026
Genetic testing in kidney transplantation and living kidney donor risk assessmentClara Schott, Sydney Relouw, Monica Arnaldi, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Nature|October 23, 2009
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A Barbie, Pablo Tamayo, Jesse S Boehm, et al.
Genes|April 26, 2025
Genetic Testing in Adults over 50 Years with Chronic Kidney Disease: Diagnostic Yield and Clinical Implications in a Specialized Kidney Genetics ClinicClara Schott, Mohammad Alajmi, Mohammad Bukhari, et al.
Cell Systems|August 25, 2017
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular StatesJong Wook Kim, Omar O Abudayyeh, Huwate Yeerna, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Scientific Data|May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependenciesGlenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Neuron|February 13, 2018
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent ExcitabilityJohn M Dawes, Greg A Weir, Steven J Middleton, et al.
Pageof 38